MusclePharm Corp. Company Profile (OTCMKTS:MSLP)

About MusclePharm Corp.

MusclePharm Corp. logoMusclePharm Corporation is a performance lifestyle company. The Company develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. The Company's portfolio of brands targets various types of fitness enthusiasts, including professional, combat sport, weight training, bodybuilding, running, basketball, soccer, cross fit, golf, tennis, volleyball and other active lifestyle activities. The MusclePharm Sport Series includes supplements that cover the needs of athletes, including their workout needs. MusclePharm Hybrid Series products include Assault, Amino1 and Combat Protein Powder. FitMiss products are designed and formulated for the active woman's lifestyle utilizing ingredients that cover the range of busy women's needs, including weight loss, multi-vitamins, protein shakes, detox, skin care and pre-workout energy mixes. MusclePharm Core products include BCAA 3:1:2, CLA Core and Fish Oil.

Industry, Sector and Symbol:
  • Sector: Consumer Staples
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: OTCMKTS
  • Symbol: MSLP
  • CUSIP:
Key Metrics:
  • Previous Close: $2.30
  • 50 Day Moving Average: $2.26
  • 200 Day Moving Average: $2.67
  • 52-Week Range: $1.68 - $4.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 4.15
  • P/E Growth: -0.07
  • Market Cap: $31.82M
  • Outstanding Shares: 13,834,000
  • Beta: 2.62
Additional Links:
Companies Related to MusclePharm Corp.:

Analyst Ratings

Consensus Ratings for MusclePharm Corp. (OTCMKTS:MSLP) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for MusclePharm Corp. (OTCMKTS:MSLP)
DateFirmActionRatingPrice TargetDetails
11/4/2014Wm SmithInitiated CoverageNot Rated$18.00View Rating Details
(Data available from 8/31/2014 forward)


Earnings History for MusclePharm Corp. (OTCMKTS:MSLP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/9/2016($0.03)($0.19)ViewN/AView Earnings Details
8/10/2015($0.19)($0.51)ViewN/AView Earnings Details
5/11/2015($0.26)($0.56)ViewN/AView Earnings Details
3/16/2015$0.01($1.39)ViewN/AView Earnings Details
11/14/2014($0.02)($0.31)ViewN/AView Earnings Details
8/4/2014($0.08)$0.03ViewN/AView Earnings Details
3/31/2014($0.50)($0.51)ViewN/AView Earnings Details
8/14/2013($0.34)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for MusclePharm Corp. (OTCMKTS:MSLP)
Current Year EPS Consensus Estimate: $-1.03 EPS
Next Year EPS Consensus Estimate: $0.52 EPS


Dividend History for MusclePharm Corp. (OTCMKTS:MSLP)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for MusclePharm Corp. (OTCMKTS:MSLP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/24/2014Andrew J LupoDirectorBuy16,010$10.62$170,026.20View SEC Filing  
11/20/2014Andrew J LupoDirectorBuy2,200$10.10$22,220.00View SEC Filing  
11/20/2014Brad J PyattCEOBuy9,900$10.09$99,891.00View SEC Filing  
11/20/2014James J GreenwellCOOBuy1,000$9.90$9,900.00View SEC Filing  
9/19/2014Gregory MacoskoDirectorBuy1,000$13.21$13,210.00View SEC Filing  
8/22/2014Brad J PyattCEOBuy5,358$12.15$65,099.70View SEC Filing  
8/14/2014Brad J PyattCEOBuy2,500$11.48$28,700.00View SEC Filing  
8/8/2014Brad J PyattCEOBuy15,000$11.27$169,050.00View SEC Filing  
8/8/2014James J GreenwellCOOBuy1,000$11.00$11,000.00View SEC Filing  
5/12/2014Michael J DoronDirectorBuy1,000$10.14$10,140.00View SEC Filing  
5/8/2014Richard EstalellaPresidentBuy10,000$9.80$98,000.00View SEC Filing  
12/6/2013Richard EstalellaCOOBuy7,000$8.06$56,420.00View SEC Filing  
12/5/2013Brad J PyattCEOBuy11,554$8.05$93,009.70View SEC Filing  
12/5/2013Lewis Gary DavisCFOBuy2,000$7.97$15,940.00View SEC Filing  
12/5/2013Sydney R RollockCMOBuy8,335$8.11$67,596.85View SEC Filing  
11/27/2013Brad J PyattCEOBuy8,800$8.48$74,624.00View SEC Filing  
11/26/2013Lewis Gary DavisCFOBuy1,000$8.30$8,300.00View SEC Filing  
11/22/2013Richard EstalellaCOOBuy3,000$8.30$24,900.00View SEC Filing  
11/22/2013Sydney R RollockCMOBuy5,000$8.25$41,250.00View SEC Filing  
11/21/2013Brad J PyattCEOBuy4,950$8.19$40,540.50View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for MusclePharm Corp. (OTCMKTS:MSLP)
DateHeadline logoMusclePharm Corp. :MSLP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 (OTCMKTS:MSLP) - August 16 at 6:26 PM
News IconMusclePharm Reports 2016 Second Quarter Monetary Outcomes. South Carolina SC (OTCMKTS:MSLP) - August 9 at 6:33 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (OTCMKTS:MSLP) - August 9 at 6:33 PM logoMUSCLEPHARM CORP Files SEC form 10-Q, Quarterly Report (OTCMKTS:MSLP) - August 9 at 6:33 PM logoMusclePharm Reports 2016 Second Quarter Financial Results (OTCMKTS:MSLP) - August 9 at 6:33 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (OTCMKTS:MSLP) - June 29 at 4:21 PM logoMusclePharm Corporation Announces More Than $45 Million in Future Commitments Trimmed To Date (OTCMKTS:MSLP) - May 26 at 4:15 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (OTCMKTS:MSLP) - May 26 at 4:08 PM logoMusclePharm Corp. :MSLP-US: Earnings Analysis: Q1, 2016 By the Numbers : May 26, 2016 (OTCMKTS:MSLP) - May 26 at 10:47 AM logoMUSCLEPHARM CORP Files SEC form 8-K, Termination of a Material Definitive Agreement (OTCMKTS:MSLP) - May 25 at 4:24 PM logoMusclePharm Reports 2016 First Quarter Financial Results (OTCMKTS:MSLP) - May 10 at 5:38 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (OTCMKTS:MSLP) - February 16 at 5:17 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Other Events (OTCMKTS:MSLP) - February 12 at 5:30 PM logoMusclePharm Focused on Expanding Market Share in Growing Protein Sector (OTCMKTS:MSLP) - January 19 at 8:15 AM logoMusclePharm Completes $10 Million Financing (OTCMKTS:MSLP) - January 14 at 8:00 AM logoMUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial (OTCMKTS:MSLP) - January 14 at 7:51 AM logoMUSCLEPHARM CORP Files SEC form 8-K, Change in Directors or Principal Officers (OTCMKTS:MSLP) - January 6 at 8:01 AM logoMusclePharm Corp. Earnings Analysis: Q3, 2015 By the Numbers (OTCMKTS:MSLP) - December 11 at 10:53 AM logoMusclePharm Executive Chairman Issues Letter to Shareholders (OTCMKTS:MSLP) - December 10 at 8:00 AM logoMUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Oblig (OTCMKTS:MSLP) - December 10 at 6:07 AM logoMUSCLEPHARM CORP Financials (OTCMKTS:MSLP) - December 8 at 1:17 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (OTCMKTS:MSLP) - November 17 at 8:03 AM logoMusclePharm to Explore Sale of Its BioZone Laboratories Nevada Subsidiary’s Business (OTCMKTS:MSLP) - November 17 at 8:00 AM logoMusclePharm Reports 2015 Third Quarter Financial Results (OTCMKTS:MSLP) - November 9 at 4:46 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations and Financial (OTCMKTS:MSLP) - November 9 at 4:43 PM logoQ3 2015 MusclePharm Corp Earnings Release - After Market Close (OTCMKTS:MSLP) - November 9 at 7:07 AM logoMusclePharm Schedules 2015 Third Quarter Financial Results (OTCMKTS:MSLP) - November 5 at 3:44 PM logoMUSCLEPHARM CORP Files SEC form 8-K, Entry into a Material Definitive Agreement (OTCMKTS:MSLP) - October 16 at 4:32 PM logoHynes Keller & Hernandez, LLC Announces Investigations of AAC Holdings, Inc., Muscle Pharm Corp., and Hill International, Inc. (OTCMKTS:MSLP) - September 23 at 7:35 AM


MusclePharm Corp. (OTCMKTS:MSLP) Chart for Wednesday, August, 31, 2016

Last Updated on 8/31/2016 by Staff